CD30:CD30 ligand interactions in the immune response.
Opat
S
S
University of Cambridge Department of Medicine, Addenbrooke's Hospital Cambridge.
Gaston
J S
JS
D000818:Animals; D017209:Apoptosis / Q000276:immunology; D053285:CD30 Ligand; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007109:Immunity; D017730:Ki-1 Antigen / Q000276:immunology*; D008024:Ligands; D008213:Lymphocyte Activation / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology
D053285:CD30 Ligand; D017730:Ki-1 Antigen; D008024:Ligands; D008562:Membrane Glycoproteins; C505774:TNFSF8 protein, human